MedTrace Logo

Endoscopic Ultrasound-Guided Ethanol Ablation for Aldosterone-Producing Adenoma

NCT07700472 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-07-14

No results posted yet for this study

Summary

This is a prospective, single-center, single-arm study evaluating endoscopic ultrasound-guided ethanol ablation for left-sided aldosterone-producing adenoma. Eligible participants will receive the ablation procedure and be followed for safety, imaging response, biochemical remission, and clinical remission. The study is expected to enroll 30 participants.

Conditions

  • Primary Aldosteronism
  • Aldosterone-Producing Adenoma

Interventions

PROCEDURE

Endoscopic Ultrasound-Guided Ethanol Ablation

Participants with left-sided aldosterone-producing adenoma undergo endoscopic ultrasound-guided ethanol ablation under real-time endoscopic ultrasound guidance.

Sponsors & Collaborators

  • Chongqing Medical University

    lead OTHER

Principal Investigators

  • Shumin Yang, MD, PhD · First Affiliated Hospital of Chongqing Medical University

  • Liang Deng, MD, PhD · First Affiliated Hospital of Chongqing Medical University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-15
Primary Completion
2028-12-31
Completion
2029-07-15

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07700472 on ClinicalTrials.gov